Latham & Watkins advised Marley Spoon on the deal, while Sullivan & Cromwell and Flick Gocke advised 468 SPAC II. 468 SPAC II SE, a publicly...
You must be a Standard 1 Year member to access this content.
Latham & Watkins advised 4D Molecular Therapeutics, while Cooley advised the underwriters for the offering. 4D Molecular Therapeutics, Inc. has announced that it priced an upsized...
You must be a Standard 1 Year member to access this content.
Cooley advised SI-BONE on the offering, and Latham & Watkins advised the underwriters involved. SI-BONE, Inc. has announced the pricing of its underwritten public offering of 3,775,000...
You must be a Standard 1 Year member to access this content.
Cooley advised Reneo, and Latham & Watkins advised the underwriters and placement agents. Reneo Pharmaceuticals, Inc. announced the pricing of its previously announced underwritten public offering of...
You must be a Standard 1 Year member to access this content.
Latham & Watkins advised Ardian on the deal. Ardian announced the acquisition of a majority stake in LIFTKET Group from Afinum. LIFTKET’s management team, led by CEO...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represents Leonard Green & Partners in the transaction, Simpson Thacher represents Hub International Limited and Hellman & Friedman, and Kirkland & Ellis represents...
You must be a Standard 1 Year member to access this content.
Latham & Watkins and Foglia & Partners advised Lottomatica, while Linklaters advised the banks involved. Paul Weiss advised Lottomatica and Gamma Topco. Lottomatica Group announced its...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represents Bosch in the transaction. Bosch has announced that it is expanding its semiconductor business with silicon carbide chips through a planned acquisition...
You must be a Standard 1 Year member to access this content.
Latham & Watkins advised CHEPLAPHARM on the offering. CHEPLAPHARM Arzneimittel GmbH announced the issuance of €750 million aggregate principal amount of New York law 144A/Reg S senior...
You must be a Standard 1 Year member to access this content.
Willkie advised Take-Two, while Latham & Watkins advised the underwriters on the deal. Take-Two Interactive Software, Inc. agreed to sell in an underwritten public offering $1.0 billion...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represents Pattern Bioscience in the deal. Pattern Bioscience, Inc. has announced the completion of a $28.7 million Series C financing. The latest funding...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented Divert in the offering. Divert Dev Co I LLC, a wholly owned subsidiary of Divert, Inc., announced it has issued through the...
You must be a Standard 1 Year member to access this content.
